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Abstract Antimicrobial peptides have been extensively studied
in order to elucidate their mode of action. Most of these peptides
have been shown to exert a bactericidal effect on the cytoplasmic
membrane of bacteria. Lactoferricin is an antimicrobial peptide
with a net positive charge and an amphipatic structure. In this
study we examine the effect of bovine lactoferricin (lactoferricin
B; Lfcin B) on bacterial membranes. We show that Lfcin B
neither lyses bacteria, nor causes a major leakage from
liposomes. Lfcin B depolarizes the membrane of susceptible
bacteria, and induces fusion of negatively charged liposomes.
Hence, Lfcin B may have additional targets responsible for the
antibacterial effect. ß 2001 Federation of European Biochem-
ical Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
Cationic antimicrobial peptides have been isolated from a
vast number of organisms [1]. They are a heterogeneous group
of peptides, varying both in primary and secondary structure.
These peptides have been extensively studied for the past de-
cade, in order to elucidate their mode of action. The bacter-
icidal e¡ect of many of these peptides is thought to be due to
the action on the cytoplasmic membrane of susceptible bac-
teria. The interaction may be through the formation of pores
[2], thinning of the membrane [3], or destabilization of the
bilayer [4]. Common for these models is a subsequent lysis
of the bacterial cell.
Some antimicrobial peptides have been shown to have addi-
tional e¡ects on the bacterial cell. Examples are indolicidin
and PR-39, which act by inhibiting protein and DNA syn-
thesis [5,6], and buforin, which inhibits cellular functions by
binding to DNA and RNA [7]. Most of these peptides also
exhibit e¡ects on the outer and inner membranes of bacteria,
and controversy has arisen about the bactericidal mode of
action of antimicrobial peptides. Whether or not the killing
event is due to the e¡ect on the membrane or disturbance of
the cellular metabolism is debated [8].
Bovine lactoferricin (lactoferricin B; Lfcin B) is a 25 amino
acid residue peptide with a net charge of +8 [9], derived from
the N-terminal part of bovine lactoferrin [10]. It has been
proven to be e¡ective against Gram-positive and Gram-neg-
ative bacteria [11], the latter in the same concentration ranges
as magainin 2 [12]. Magainin 2 acts on the cytoplasmic mem-
brane, forming transient pores causing the death of the bac-
terial cells.
The mode of action of Lfcin B is not yet elucidated, but due
to its amphipatic structure and positive charge, it has been
postulated to act on the cytoplasmic membrane [10]. The se-
lectivity of Lfcin B may be due to the presence of negatively
charged fatty acids in the bacterial membrane. To test these
hypotheses, we have studied the e¡ect of Lfcin B on mem-
branes.
2. Materials and methods
2.1. Reagents
Lfcin B was prepared by pepsin digestion of bovine lactoferrin by
Centre for Food Technology (Qld., Australia). JC-1 (5,5P,6,6P-tetra-
chloro-1,1P,3,3P-tetraethyl-benzimidazolcarbocyanine iodide) was ob-
tained from Molecular Probes (OR, USA), while valinomycin, melli-
tin, propidium iodide (PI), phospholipids, sodium cholate, Triton X-
100 and calcein were purchased from Sigma, St. Louis, MO, USA.
PD10 columns containing Sephadex G-25 were obtained from Amer-
sham Pharmacia Biotech AB, Sweden.
2.2. Minimal inhibitory concentration (MIC) and minimal bactericidal
concentration (MBC) determination
Determination of MIC and MBC of Lfcin B was performed using a
standard microdilution technique in 1% bacto peptone water (BPW)
pH 6.8, as previously described by Vorland et al. [13]. For determi-
nation of the MBC, aliquots of 10 Wl were transferred onto agar
plates. The plates were incubated overnight at 37‡C and the colony
forming units (CFU) determined. The MBC was set as the concen-
tration reducing the CFU by 99%.
2.3. Preparation of liposomes
To study leakage of vesicle content, the self-quenching dye calcein
was entrapped in liposomes, using a bu¡er of pH 7.5 containing
5 mM calcein, 100 mM NaCl and 5 mM EDTA [14]. Intermediate
unilamellar vesicles (IUV) were prepared by dissolving lipids and so-
dium cholate at a ratio of 1:1 (mol:mol) in calcein bu¡er to a ¢nal
concentration of 5 mg lipid per ml bu¡er. The lipids were incubated at
60‡C overnight to allow formation of micelles. The micelle solutions
were dialyzed using a Liposomat (Dianorm, Munich, Germany) at
60‡C against bu¡er until conversion to liposomes. The liposomes
were ¢ltered through a 0.22 Wm ¢lter, and analyzed by dynamic light
scattering (Coulter N4S, Beckman) to ensure size distribution and
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lamellarity. Neutral liposomes were made of diphosphatidyldipalmi-
toylcholine (DPPC), and negatively charged liposomes of 80% DPPC
and 20% diphosphatidyldipalmitoylglycerol (DPPG) or 20% diphos-
phatidyldipalmitoylserine (DPPS). Palmitoyl (C16:0) was chosen to
mimic the natural character of bacterial membranes.
Empty liposomes were prepared for the fusion study, and contained
33% DPPG or DPPS in DPPC vesicles. Small unilamellar vesicles
(SUV) were prepared using high-pressure extrusion technique [15].
A solution of 20% phospholipids in bu¡er (100 mM NaCl and
5 mM EDTA) was extruded 10 times through a Micron Lab 40
APV Gaulin-Homogenizer (Lubeck, Germany) at a pressure of 700
bar. Size distribution was measured using dynamic light scattering.
2.4. Leakage from liposomes
The liposomes were separated from unentrapped calcein by double
¢ltration through Sephadex G-25. The liposomes were then diluted in
calcein free bu¡er to a ¢nal concentration of 10 WM lipid. Lfcin B was
added to the liposomes to yield concentrations of 10, 50 and 100 Wg/
ml liposomes, and incubated at 37‡C for 15, 30, 45, 60 and 120 min.
Release of the entrapped dye will cause a dilution of calcein and an
increase in £uorescent intensity. Relative £uorescence intensity was
measured on a Perkin Elmer Luminescens Fluorimeter LS-50B (Vex
490 nm, Vem 520 nm). The background £uorescent intensity from
liposomes without peptide or detergent was measured as negative
control at each time point. 10% Triton X-100 was added to the lipo-
somes to induce maximum release of the entrapped dye. Relative
leakage was calculated using Graph PadPrism 3.0 software for Win-
dows (Graph Pad Software Inc.). The following formula was used:
relative leakage = ((Fx3F0)U100)/(Ft3F0) where Fx is the intensity
measured at a given concentration of Lfcin B, F0 is the intensity of
the liposomes (background) and Ft is the intensity after collapse by
Triton X-100.
2.5. Fusion of liposomes
Fusion of SUV was determined using changes in absorbance at 400
nm as previously described by Fujii et al. [16]. Measuring the absor-
bance at 400 nm gives an indication of changes in liposome size, due
to fusion of vesicles. The absorbance was measured after exposing the
SUV to 0, 10, 50 and 100 Wg/ml Lfcin B. Further, changes in particle
size were measured using dynamic light scattering after exposure to
the same concentrations of Lfcin B as performed in the leakage assay.
2.6. E¡ect on membranes in whole cells
Escherichia coli ATCC 25922 and Proteus mirabilis ATCC 35659
were grown to mid-logarithmic phase in 2% BPW and adjusted to a
density of approximately 1U106 CFU/ml. Six aliquots of the bacterial
suspension were drawn; one served as negative control, one as pos-
itive control. To the last four, Lfcin B was added to a ¢nal concen-
tration of 15, 30, 70 and 100 Wg/ml. The peptide^bacteria solutions
were incubated at 37‡C for 1 and 2 h before staining. PI was dissolved
in double distilled sterile water to a stock concentration of 10 mg/ml,
and added to the bacteria to give a ¢nal concentration of 10 Wg/ml,
then allowing 5 min to stain before analyzing [17]. Ethanol-treated
cells were used as a positive control, indicating maximal uptake of PI.
JC-1 was dissolved in DMSO to a stock concentration of 10 mg/ml,
and stored in the dark at room temperature until used. JC-1 was
added to the bacteria to give a ¢nal concentration of 1 Wg/ml. The
cells were incubated in the dark at room temperature for 15 min to
allow uptake of the dye [18]. The cells were then washed twice and
resuspended in 2% BPW before analyzing. Valinomycin-treated cells
(200 nM) were used as positive control.
2.7. Flow cytometric analysis
The analysis was performed on a FACScan (Becton Dickinson,
New Jersey, USA) equipped with an argon laser with a single wave-
length at 488 nm. Uptake of JC-1 was detected using FL2 (Vem 585
nm þ 25 nm) and depolarization detected as a shift in £uorescence
from FL2 to FL1 (Vem 530 nm þ 30 nm). PI (Vem 617 nm) uptake
was detected as an increase in FL2 emission.
2.8. Electron microscopy
E. coli ATCC 25922 was grown to mid-logarithmic phase in 2%
BPW, and further diluted in 2% BPW to a ¢nal concentration of
2U106 CFU/ml. Equal amounts of bacteria and Lfcin B (dissolved
in water) were mixed to give a total volume of 100 ml, yielding a ¢nal
concentration of 24 Wg/ml Lfcin B (0.8UMIC). The solutions were
placed in a water shaker (37‡C) for 60 min, and then centrifuged for
10 min at 1700Ug, and the pellet kept for electron microscopy.
The specimens were cut and washed in phosphate bu¡er prior to
post¢xation in 1% aqueous OsO4 for 2 h. The specimens were then
block-stained in 2% aqueous uranyl acetate, dehydrated in graded
ethanol concentrations, and subsequently embedded in Epon/Araldite.
Ultrathin sections were cut on a RMC MT-7 ultramicrotome, con-
trasted for 12 min in 5% aqueous uranyl acetate and 10 min in Rey-
nolds lead citrate. The sections were examined with a JEOL JEM
1010 electron microscope, and micrographs taken on Kodak Electron
Microscope ¢lm No. 4489.
2.9. Lysis assay
E. coli ATCC 25922 was grown in 2% BPW to 2U108 CFU/ml,
harvested, washed twice in phosphate-bu¡ered saline (pH 7.4) and
then resuspended in 2% BPW to yield V107 CFU/ml. Aliquots of
100 Wl bacteria and 100 Wl Lfcin B (yielding concentrations ranging
from zero to 100 Wg/ml) were added to a microtiter tray. The OD630 nm
was read in a Spectramax0PLUS (Molecular Devices, CA, USA) for
1 h, reading interval 1 min at 37‡C. A reduction in OD630 nm was
interpreted as lysis of the bacteria [7].
2.10. E¡ect of osmotic pressure
Swelling of bacterial cells was monitored at 420 nm using Spectra-
max0PLUS [19]. In a microtiter tray, aliquots of 75 Wl E. coli at mid-
logarithmic growth, 75 Wl Lfcin B (dissolved in water) and 75 Wl water
or 0.3 poly ethylene glycol were added to yield ¢nal concentrations of
Lfcin B between zero and 100 Wg/ml. The increase in absorbance at
420 nm was monitored in a Spectramax0PLUS at intervals of 10 min
for 2 h, and the data analyzed using Graph PadPrism 3.0.
3. Results
The MICs and MBCs of Lfcin B against E. coli and P.
mirabilis were determined. E. coli had a MIC of 30 Wg/ml
and MBC of 70 Wg/ml, while P. mirabilis was less susceptible
with a MIC above 200 Wg/ml (MBC not detected).
Liposomes of di¡erent composition were exposed to 10, 50
and 100 Wg/ml Lfcin B. Release of vesicle content was mea-
sured as an increase in relative £uorescent intensity caused by
dilution of the self-quenching dye calcein. Fig. 1 shows the
relative leakage from vesicles after exposure to Lfcin B. An
initial increase in £uorescent intensity was observed (15 min),
before the intensity decreased (1 h), and then maximum re-
lease of vesicle content from DPPS vesicles was detected at 2 h.
The leakage from all liposomes was minimal, and at no point
of time did the leakage exceed 25%. A minor leakage was
detected from the neutral liposomes (DPPC), but this was
not signi¢cant compared to the leakage from the charged lipo-
somes.
Fig. 1. Relative leakage from IUV induced by 100 Wg/ml Lfcin B
plotted as a function of time (S DPPG, 8 DPPS, b DPPC).
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Fig. 2 shows that the absorbance of the liposome:peptide
solution increased with increasing peptide concentration. The
increase was greatest when measured on the DPPS containing
liposomes. To verify the increase in vesicle size, the mean
particle size and size distribution were measured using dynam-
ic light scattering. These results were consistent, and showed
that the vesicle size increased 200-fold with increasing concen-
trations of Lfcin B (data not shown). The DPPS population
displayed the largest liposomes.
Fig. 3 illustrates the e¡ect on the cytoplasmic membrane of
whole bacteria. Lfcin B caused a depolarization of the cyto-
plasmic membrane in E. coli, whilst the membrane of P. mir-
abilis was not depolarized. The depolarization was concentra-
tion dependent, indicated by a greater JC-1 uptake with
increasing concentrations of Lfcin B. A greater proportion
of the E. coli population was depolarized and damaged than
in the population of P. mirabilis. There was only a minor
uptake of PI by the bacteria exposed to Lfcin B.
Morphological changes as visualized by electron microsco-
py were evident at concentrations below the MIC. Fig. 4
shows a micrograph of E. coli exposed to 30 Wg/ml Lfcin B.
The bacterial cells were intact, and the content of the cell was
still inside. The bacterial cells did not appear swollen, but
there appeared to be a separation of the cell envelope. Further
examination reveals blebs containing bilayer structures on the
bacterial surface, extruding from the cytoplasmic membrane,
and released to the surroundings of the bacteria.
Lfcin B did not lyse E. coli, as measured by OD630 nm. No
reduction in OD was observed. An increase in OD was ob-
served even at concentrations above the MIC. Adding poly
ethylene glycol to the external medium had no e¡ect on the
measured absorbance at 420 nm. Equalizing the osmotic pres-
sure did not counteract the e¡ect Lfcin B exerts on the bac-
teria.
4. Discussion
Several studies report a correlation between increased per-
meability and antimicrobial activity of antimicrobial peptides.
Hence, the paradigm of today is that the membrane destabi-
lizing e¡ect is responsible for the antimicrobial activity.
Our results show that Lfcin B destabilizes liposomes, caus-
ing leakage and fusion. The greatest leakage of liposome con-
tent was observed from negatively charged liposomes. This is
in accordance with the results presented by Matsuzaki et al. in
a study performed with magainin 2 and liposomes [20]. How-
ever, the leakage induced by Lfcin B is minor when compared
to other antimicrobial peptides with a known e¡ect on the
cytoplasmic membrane [21,22]. Subsequent to the initial leak-
age, further exposure to Lfcin B caused the acidic vesicles to
rearrange (i.e. fuse) rather than to leak, and Lfcin B induced a
10-fold increase in size of the negatively charged liposomes.
Defensin-induced fusion of liposomes has been reported, but
the biological signi¢cance of the fusion process is poorly
Fig. 2. Fusion of negatively charged vesicles represented by change
in absorbance at 400 nm. The absorbance increases with increasing
size of the vesicles. SUV were exposed to 0, 10, 50 and 100 Wg/ml
Lfcin B for 60 min at room temperature. Bars indicate S.E.M.
, DPPG; , DPPS.
Fig. 3. The e¡ect on bacterial membranes induced by Lfcin B after
2 h as % cells with depolarized membranes (measured as uptake of
JC-1) plotted against % cells with damaged membrane integrity
(measured by PI uptake). F E. coli. S P. mirabilis.
Fig. 4. Electron micrograph of E. coli exposed to 30 Wg/ml Lfcin B.
Morphological changes include the formation of blebs on the bacte-
rial surface. The open arrow points out the formation of blebs on
the bacterial surface, and the closed arrow the separation of the cell
envelope.
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understood [16]. However, the event does enable a transloca-
tion of the peptide molecules across the membrane bilayer.
The ¢ndings reported above are supported by the results
obtained from the experiments performed on whole bacteria.
Lfcin B does not lyse the bacterial strain tested here, nor is the
osmotic pressure important for the e¡ect of the peptide. As
indicated by a low uptake of PI, we reveal no signi¢cant
damage to the integrity of the cytoplasmic membrane. PI is
a small cationic dye excluded from cells with intact membrane
[23]. Lfcin B caused a depolarization of the cytoplasmic mem-
brane, indicated by a shift in £uorescent properties of JC-1.
JC-1 is a lipophilic cationic probe, originally used to analyze
the membrane potential of mitochondria [18]. All cells take up
JC-1, but JC-1 changes £uorescent properties as the cells be-
come depolarized. This e¡ect is only exerted on E. coli, the
most susceptible strain. Whether the depolarization is a result
of a direct action on the membrane, or a secondary result
from an attack on metabolic pathways, is not possible to
determine based on these experiments.
We show that Lfcin B favors interactions with negatively
charged phospholipids, inducing a small leakage of vesicle
content. The small leakage observed could be an e¡ect of a
transient channel formation process, as proposed for maga-
inin 2 and mellitin [20]. This is however not likely, since the
e¡ect of Lfcin B is not a¡ected by osmotic pressure. The
major e¡ect on acidic liposomes is fusion of the vesicles.
The initial increase in £uorescent intensity observed after ex-
posure to Lfcin B may not be a result of a true leakage, but
mainly a result of re-encapsulation of dye during the fusion
process itself as proposed for other peptides [16]. The fusion
process may represent a mean of transport across the lipid
barrier, enabling translocation and opening for the possibility
for the peptide to reach cytoplasmic targets.
We show that Lfcin B selectively induces fusion of nega-
tively charged liposomes, an event representing the probable
selectivity basis of the peptide. Lfcin B does not cause in-
creased permeability of membranes in intact bacteria, but
causes depolarization and formation of blebs on the bacterial
surface. The peptide may cause the cytoplasmic membrane to
curl up on itself, fuse due to the hydrophobic character of the
bilayer, and thus forming blebs. The peptide may be anchored
to the blebs, or may be translocated into the cytoplasm during
this event. The e¡ect of Lfcin B is not dependent upon os-
motic pressure, since Lfcin B exerts its e¡ect on the bacteria
even after the osmotic pressure was equalized across the enve-
lope. Neither do the cells undergo lysis, which is an essential
result of pore formation. A more detailed model for the mech-
anisms responsible for the bactericidal e¡ect of Lfcin B is not
elucidated at this point.
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